NATURAL KILLER CELLS WEAKLY RESIST ENGRAFTMENT OF ALLOGENEIC, LONG-TERM, MULTILINEAGE-REPOPULATING HEMATOPOIETIC STEM CELLS1
- 1 January 1996
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (1) , 125-132
- https://doi.org/10.1097/00007890-199601150-00024
Abstract
Natural killer (NK) cells effect hybrid resistance, in which parental hematopoietic cell grafts are rejected by F1 recipients. NK cells can also resist engraftment of fully MHC-mismatched allogeneic marrow. However, studies of NK cell-mediated alloresistance have relied on short-term proliferation, colony, or survival assays; therefore, their results may not reflect effects of NK cells on the engraftment of allogeneic pluripotent hematopoietic stem cells (PHSC). We have now addressed the role of NK cells in resisting engraftment of these most primitive hematopoietic cells, which provide long-term repopulation of multiple hematopoietic lineages. We took advantage of a nonmyeloablative conditioning regimen that permits allogeneic marrow engraftment and induction of mixed chimerism in mice to evaluate the effect of host NK cell depletion with mAb PK136 on long-term competitive repopulating ability of allogeneic marrow. Mice were pretreated with depleting anti-CD4 and anti-CD8 mAbs, then received 3 Gy of whole body irradiation and 7 Gy of thymic irradiation prior to allogeneic bone marrow transplantation. Depending on the strain combination used, statistically significant increases in long-term allogeneic repopulation of both myeloid and lymphoid cell lineages were observed in recipients depleted of NK cells before bone marrow transplantation compared with controls. Depletion of host NK cells alone was sufficient to enhance donor PHSC engraftment. However, a statistically significant increase in allogeneic reconstitution in NK cell-depleted chimeras compared with control chimeras was not observed in every experiment, and differences were most readily apparent in a strain combination in which recipient NK cells have been shown to have high resistance to engraftment of donor short-term repopulating cells. Chronic (16 weeks) anti-NK1.1 treatment resulted in higher levels of donor-type repopulation than that in animals receiving only pretransplant NK cell depletion. Our studies demonstrate for the first time that host NK cells resist engraftment of allogeneic long-term repopulating PHSC, and provide a model for studying the elements that determine what is regarded as “self” and “non-self” by newly developing NK cells.Keywords
This publication has 31 references indexed in Scilit:
- Heterogeneity of hematopoietic stem cellsCurrent Opinion in Immunology, 1993
- A DECREASE IN GRAFT-VS.-HOST DISEASE WITHOUT LOSS OF GRAFT-VS.-LEUKEMIA REACTIVITY AFTER MHC-MATCHED BONE MARROW TRANSPLANTATION BY SELECTIVE DEPLETION OF DONOR NK CELLS IN VIVOTransplantation, 1992
- Effects of interleukin-2 and interleukin-2-activated cells on in vitro myelopoiesisClinical and Experimental Immunology, 1990
- Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.The Journal of Experimental Medicine, 1989
- ABSENCE OF A FACILITORY ROLE FOR NK 1.1-POSITIVE DONOR CELLS IN ENGRAFTMENT ACROSS A MAJOR HISTOCOMPATIBILITY BARRIER IN MICE1,2Transplantation, 1988
- Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.The Journal of Experimental Medicine, 1988
- Evaluation of HLA‐Haplotype Disparate Parental Marrow Grafts Depleted of T Lymphocytes by Differential Agglutination with a Soybean Lectin and E‐Rosette Depletion for the Treatment of Severe Combined Immunodeficiency1Vox Sanguinis, 1986
- MONOCLONAL ANTIBODIES TO MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENSTransplantation, 1982
- „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cellEuropean Journal of Immunology, 1975
- PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTSThe Journal of Experimental Medicine, 1971